Bhagavati S. Autoimmune disorders of the nervous system: pathophysiology, clinical features, and therapy. Front Neurol. 2021;12:664664.
Article PubMed PubMed Central Google Scholar
Pisetsky DS. Pathogenesis of autoimmune disease. Nat Rev Nephrol. 2023;19(8):509–24.
Article PubMed CAS Google Scholar
Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA. The epidemiology of myasthenia gravis. J Med Life. 2021;14(1):7.
Article PubMed PubMed Central Google Scholar
Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis—autoantibody characteristics and their implications for therapy. Nat Rev Neurol. 2016;12(5):259–68.
Article PubMed CAS Google Scholar
Zhu Y, Wang B, Hao Y, Zhu R. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Front Immunol. 2023;14:1223322.
Article PubMed PubMed Central CAS Google Scholar
Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, Shohaimi S, Mohammadi M. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med. 2021;19:1–23.
Ganesan A, Gopalakrishnan S, Golla DV. A case report of Guillain-Barre syndrome with demyelinating polyradiculoneuropathy. Romanian J Diabetes Nutr Metab Dis. 2022;29(4):476–9.
Jacob S, Kapadia R, Soule T, Luo H, Schellenberg KL, Douville RN, Pfeffer G. Neuromuscular complications of SARS-CoV-2 and other viral infections. Front Neurol. 2022;13:914411.
Article PubMed PubMed Central Google Scholar
Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. J Neurol. 2018;265:1251–8.
Article PubMed CAS Google Scholar
Li L, Xiong WC, Mei L. Neuromuscular junction formation, aging, and disorders. Annu Rev Physiol. 2018;80:159–88.
Article PubMed CAS Google Scholar
Berrih-Aknin S, Le Panse R. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun. 2014;52:90–100.
Article PubMed CAS Google Scholar
Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235.
Article PubMed PubMed Central CAS Google Scholar
Dong J, Duan RS, Zhang P. Causal relationship between the immune phenotype of monocytes and myasthenia gravis: A Mendelian randomization study. Heliyon. 2024;10(5):e26741.
Article PubMed PubMed Central CAS Google Scholar
Uzawa A, Kuwabara S, Suzuki S, Imai T, Murai H, Ozawa Y, Yasuda M, Nagane Y, Utsugisawa K. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol. 2021;203(3):366–74.
Article PubMed CAS Google Scholar
Tadjievna KD, Bakhtiyarova IN. Incidence of thymus gland pathology in patients with myasthenia gravis (literature review). World Bull Pub Health. 2022;30(13):202–5.
Misawa S, Suichi T. Guillain-Barré syndrome: Novel treatment by complement inhibition. Clin Exp Neuroimmunol. 2020;11(2):90–3.
Berciano J. Axonal pathology in early stages of Guillain-Barré syndrome. Neurologia. 2022;37(6):466–79.
Patnaik UJ. Review article on COVID-19 and Guillain-Barré syndrome. Front Biosci-Sch. 2021;13(1):97–104.
Finsterer J. Triggers of Guillain-Barré syndrome: campylobacter jejuni predominates. Int J Mol Sci. 2022;23(22):14222.
Article PubMed PubMed Central CAS Google Scholar
Li T, Wolfert MA, Wei N, Huizinga R, Jacobs BC, Boons GJ. Chemoenzymatic synthesis of Campylobacter jejuni lipo-oligosaccharide core domains to examine Guillain-Barre syndrome serum antibody specificities. J Am Chem Soc. 2020;142(46):19611–21.
Article PubMed PubMed Central CAS Google Scholar
Khan SA, Das PR, Nahar Z, Dewan SM. An updated review on Guillain-Barré syndrome: Challenges in infection prevention and control in low-and middle-income countries. SAGE Open Med. 2024;12:20503121241239536.
Article PubMed PubMed Central Google Scholar
Wu CL, Chao CH, Lin SW, Chien YY, Huang WY, Weng WC, Su FC, Wei YC. Case report: Plasma biomarkers reflect immune mechanisms of guillain-barré syndrome. Front Neurol. 2021;12:720794.
Article PubMed PubMed Central Google Scholar
Yuan J, Zhang J, Zhang B, Hu W. The clinical features of patients concurrent with Guillain-Barre syndrome and myasthenia gravis. Neurosci J. 2018;23(1):66–70.
Croitoru CG, Cuciureanu DI, Hodorog DN, Grosu C, Cianga P. Autoimmune myasthenia gravis and COVID-19. A case report-based review. J Int Med Res. 2023;51(8):03000605231191025.
Article PubMed PubMed Central Google Scholar
Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: Biology and clinical disease. Cell. 2022;185(20):3652–70.
Article PubMed PubMed Central CAS Google Scholar
Frappier L. Epstein-barr virus: Current questions and challenges. Tumour Virus Res. 2021;12:200218.
Article PubMed PubMed Central Google Scholar
Silva JD, Alves CE, Pontes GS. Epstein-Barr virus: the mastermind of immune chaos. Front Immunol. 2024;15:1297994.
Article PubMed PubMed Central Google Scholar
Cavalcante P, Marcuzzo S, Franzi S, et al. Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? Oncotarget. 2017;8(56):95432–49.
Article PubMed PubMed Central Google Scholar
Cavalcante P, Serafini B, Rosicarelli B, Maggi L, Barberis M, Antozzi C, Berrih-Aknin S, Bernasconi P, Aloisi F, Mantegazza R. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol. 2010;67(6):726–38.
Nishio M, Saito M, Yoshimori M, Kumaki Y, Ohashi A, Susaki E, Yonese I, Sawada M, Arai A. Clinical significance of anti-Epstein–Barr virus antibodies in systemic chronic active Epstein-Barr virus disease. Front Microbiol. 2024;14:1320292.
Article PubMed PubMed Central Google Scholar
Elendu C, Osamuyi EI, Afolayan IA, Opara NC, Chinedu-Anunaso NA, Okoro CB, Nwankwo AU, Ezidiegwu DO, Anunaso CA, Ogbu CC, Aghahowa SO. Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review. Medicine. 2024;103(30):e38890.
Article PubMed PubMed Central Google Scholar
Mahmood H, Kiani M, Madani Y. ‘A kiss that took my legs away’: a rare presentation of Epstein-Barr virus in the older population. Clin Med. 2023;23(6):621–4.
Wallace LA, English SW, Fugate JE, Tosh PK. Acute epstein-barr virus infection presenting as guillain-barre syndrome. IDCases. 2021;25:e01196.
留言 (0)